SciBase: New study shows Nevisense significantly improves US clinician's decision-making beyond dermoscopy
STOCKHOLM, Oct. 26, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a
Source: finanznachrichten.de